East/West CEO
Date: Location: Cost:
January 5 - 6, 2019 Four Seasons Hotel
757 Market Street
San Francisco, CA 94103
(415) 633-3000

Starting at $1950

 

Dress Code:
Business Attire

Register

EAST/WEST CEO – January 5, 2019 - DRAFT AGENDA

Co-hosts: Stephen Cutler, Michael Hayden, Tom Heyman, Edward Kaye, Ivana Magovcevic-Liebisch, Sean McCarthy, Lisa McKerracher, John Mendlein, Paris Panayiotopoulos, David Pyott, John Reed, James Sapirstein, Paul Stoffels, Christoph Westphal

Time Agenda
8:00-9:00 am

Registration and Networking Breakfast

9:00-9:30 am

Welcoming Remarks
Diarmaid Cunningham, CAO, ICON; Paris Panayiotopoulos, President & CEO Emeritus, ARIAD Pharmaceuticals

9:30-10:00 am

Building a Biotech: Innovative Business Models
Punit Dhillon, President, OncoSec Medical; Lisa McKerracherFounder & CEO, BioAxone BioSciences; Hamza Suria, President & CEO, AnaptysBio
Moderator: Jack ReichCEO, Renova Therapeutics 

10:00-10:30 am

Private Company Perspectives on Raising Capital and Partnering
Adam Bruce, CEO, TikoMed; Felix Karim, EVP, Business Development, Blade Therapeutics
Moderator: Donald NicholsonCEO, Nimbus Therapeutics

10:30-11:00 am

Funding Innovation While Balancing Risk: The VC Perspective
Marianne De Backer, VP, Venture Investments, Johnson & Johnson; Ken HaasPartner, Abingworth; Rekha Hemrajani, COO, FLX Bio; Thomas MalcolmPresident & CEO, Excision Biotherapeutics; Mary Rozenman, SVP, Corporate Development & Strategy, Aimmune Therapeutics
Moderator: Vas BaileyVenture Partner, ARTIS Ventures

11:00-11:30 am

Moderated Keynote
Gregory Simon
, President, Biden Cancer Initiative
Moderator: 
Paris Panayiotopoulos, President & CEO Emeritus, ARIAD

11:30-12:00 pm

Digital Value in Therapeutics
Thomas LonngrenFormer Executive Director, European Medicine Agency; Wasim MalikChief Digital Strategist, Roivant Sciences; Kenneth MunieManaging Director, Accenture
Moderator: Robert BratzlerCo-founder & CEO, BioTrak Therapeutics

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

D&I:The Measurable Benefits of Diverse Perspectives on Revenue, Innovation and Disruption
Meeta Chatterjee, Head of Strategy, Transactions & Operations, Merck; Ivana Magovcevic-LiebischEVP, Chief Strategy & Corporate Development Officer, Axcella Health; Lisa McKerracher, Founder & CEO, BioAxone BioSciences; James Sapirstein, CEO, Contravir Pharmaceuticals
Moderator: Julie Kampf, CEO, JBK Associates

1:30-2:00 pm

Global Markets: Biotech Access Across Borders
Luigi Costa, CEO, Nordic Nanovector ASA; Samantha Du, Chairman & CEO, Zai Laboratory; Carl Firth, CEO, Aslan Pharmaceuticals; Brian McVeigh, CEO, KBP Biosciences
Moderator: Mark Rothera, CEO, Orchard Therapeutics

2:00-2:30 pm

Accessing Innovation in Drug Development
Charles Baum, CEO, Mirati Therapeutics; Colin Broom, CEO,Nabriva Therapeutics; Rowan ChapmanHead of Innovation, California, Johnson & Johnson; Michael Hayden, CSO & President, Global R&D, Teva
Moderator: Diarmaid Cunningham, CAO, ICON

2:30-3:00 pm

Large Biotech and Pharma Perspectives: Predictions for 2018
Luc DochezCEO, Tusk Therapeutics; Gilmore O'Neill, SVP, Drug Innovation Units, Biogen; Sara Radcliffe, President & CEO, California Life Sciences Association; John Reed, Global Head of Pharma Research & Early Development, Roche
Moderator: Jeremy GoldbergAdvisor, TPG

3:00-3:30 pm

Networking Break

3:30-4:00 pm

New Trends in Oncology & Immunotherapy
Leena Das-Young, VP-Head of Late Phase Strategy & Development Group, Pfizer; Axel Hoos, SVP, Therapeutic Area Head, Oncology R&D, GlaxoSmithKline; Pascal TouchonGlobal Head Cell & Gene, Novartis Oncology; Debi Watson, VP, Janssen Business Development, Oncology, Johnson & Johnson
Moderator: Paris PanayiotopoulosPresident & CEO Emeritus, ARIAD Pharmaceuticals

4:00-4:30 pm

R&D Trends: What's Changed in the Pharma Pipeline?
Tom Hallam, CEOLeading BioScience; Arthur Krieg, CEO, Checkmate Pharmaceuticals; Henry Ji, CEO, Sorrento Therapeutics
Moderator: 
Malcolm Weir, CEO, Heptares

4:30-6:00 pm

Cocktails and Hors d'oeuvres

January 6, 2019

Co-hosts: Stephen Cutler, Michael Hayden, Tom Heyman, Edward Kaye, Ivana Magovcevic-Liebisch, Sean McCarthy, Lisa McKerracher, John Mendlein, Paris Panayiotopoulos, David Pyott, John Reed, James Sapirstein, Paul Stoffels, Christoph Westphal

Time Agenda
7:30-8:40 am

Registration and Networking Breakfast

8:40-8:50 am

Welcoming Remarks
Julie KampfCEOJBK Associates; John Nicols, President & CEO, Codexis; Patrick Verheyen, Global Head, Janssen Business Development, Johnson & Johnson

8:50-9:20 am

Global Perspectives on Funding and Innovation
Gil Beyen
Chairman & CEO, ErytechTom Heyman, President, JJDC, Johnson & Johnson Innovation; Jonathan Isaacsohn,CEO, CinRx Pharmaceuticals
Moderator: Ken HorneCEO, Symic Bio

9:20-9:50 am

State of the Healthcare Industry: Building a Sustainable Future
Parker Cassidy, CCO, Mitra Biotech; Sean McCarthy, CEO, CytomX; Bill Newell, CEO, Sutro Biopharma; Daniel Paterson, COO, Verastem
Moderator: Philippe Lopes-Fernandes, SVP, Global Head of Licensing, BD & Alliance Management, EMD Serono

9:50-10:20 am

Moderated Keynote
David Pyott
, former Chairman & CEO, Allergan
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund

10:20-10:50 am

Networking Break

10:50-11:20 am

Evolving Biopharma Boards
Martin Babler, CEO, Principia Biopharma; William Heiden, President & CEO, AMAG Pharmaceuticals; Catherine Sohn, Chairman, BioEclipse Therapeutics
Moderator: Adam Bruce, CEO, TikoMed

11:20-11:50 am

Challenges and Opportunities in Biotech
Alan Ezekowitz, CEO, Abide Therapeutics; Denise McGinn,VP, Janssen Business Development, Cardiovascular Metabolism/Japan, Johnson & Johnson; Joe Payne, President & CEO, Arcturus Therapeutics
Moderator: Robert Forrester, CEO, Verastem

11:50-12:20 pm

Biotech Partnering: Strategies for Success
Dan O’Connor, CEO, OncoSec Medical; David MalekCBO, BioLineRx; John Oyler, Founder & CEO, BeiGene; Prakash Raman, Global Head, NIBR BD&L, Novartis; Allan Shaw, Board Member & Chairman of Compensation Committee, Vivus
Moderator: Jonathan Kfoury, Managing Partner, L.E.K. Consulting

12:20-1:20 pm

Networking Lunch

1:20-1:50 pm

Moderated Keynote
Paul Stoffels
, EVP & CSO, Johnson & Johnson
Moderator: John Nicols, President & CEO, Codexis

1:50-2:20 pm

Venture Philanthropy and Entrepreneurship: Advancing Medical Innovation
James Dao, Chairman and CEO, Genyous Biomed; Anne Deconinck, Executive Director, MIT Koch Institute; Charlotte Hubbert, Partner, Gates Foundation Venture Capital
Moderator: Mark SimonManaging Director, Torreya Partners

2:20-2:50 pm

Trends in Private Financing & Capital: Leveraging Potential
Julie Eastland, CFO & CBO, Cascadian Therapeutics; Shalabh Gupta, Founder & CEO, Globavir BioScience; Aram Mangasarian, CEO, NOXXON Pharma
Moderator: Edward Kaye, CEO, Stoke Therapeutics

2:50-3:20 pm

Networking Break

3:20-3:50 pm

Media Perspectives: Reporting on Biotech **
Matt Herper, Senior Editor, Forbes Magazine; Lydia Ramsey, Biotech & Pharma Reporter, Business Insider; Ed Silverman, Senior Writer & Pharmalot Columnist, STAT News; Meg Tirrell, Biotech & Pharma Reporter, CNBC
Moderator: Seema KumarVP, Innovation, Global Health and Science Policy Communication, Johnson & Johnson

** This session is Off the Record

3:50-4:00 pm

Presentation of Lifetime Achievement Award
Tom Heyman
, 2017 Honoree; David Pyott, 2016 HonoreePaul Stoffels, 2014 Honoree

4:00-5:00 pm

Cocktails and Hors d'oeuvres

Executive Sponsors: (see all sponsors)

<